Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.

Saved in:
Bibliographic Details
Title: Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis.
Authors: Heseltine J; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK. J.heseltine@nhs.net.; The University of Liverpool, Liverpool, UK. J.heseltine@nhs.net., Allison J; The Christie, Manchester, UK., Wong S; The Royal Marsden, London, UK., Prasad K; East Lancashire Teaching Hospitals, Lancashire, UK., Oong ZC; East Lancashire Teaching Hospitals, Lancashire, UK., Wong H; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK., Law A; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK., Charnley N; East Lancashire Teaching Hospitals, Lancashire, UK., Parikh O; East Lancashire Teaching Hospitals, Lancashire, UK., Waddell T; The Christie, Manchester, UK., Chow S; The Clatterbridge Cancer Centre, Clatterbridge Road, Bebington, Liverpool, CH63 4JY, UK.
Source: Targeted oncology [Target Oncol] 2023 Jul; Vol. 18 (4), pp. 593-599. Date of Electronic Publication: 2023 Jun 07.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first